NCT00310466View on ClinicalTrials.gov

Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever

PHASE3CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

January 31, 2007

Conditions
Allergy
Interventions
BIOLOGICAL

Sublingual immunotherapy

once daily intake of sublingual drops

BIOLOGICAL

Placebo

once daily intake of sublingual drops

Trial Locations (1)

D-10117

Charité Klinik für Dermatologie, Venerologie und Allergologie, Berlin

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT00310466 - Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever | Biotech Hunter | Biotech Hunter